Stay updated on Switching to Cabotegravir and Rilpivirine: Clinical Trial

Sign up to get notified when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Switching to Cabotegravir and Rilpivirine: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide banner announces that NIH is transitioning to the term “Super Intelligence” in place of “Artificial Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T14:07:49.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-18T14:34:43.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer's site revision identifier updates from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T15:17:22.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    403 Forbidden error header now appears on the page, with a Home link and a Revision: v3.7.0 notice, replacing the previous study content and signaling that the page is inaccessible.
    Difference
    21%
    Check dated 2026-09-20T20:16:33.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page adds a note about a 2016 NIH grant/contract. It also updates the revision to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.0%
    Check dated 2026-08-30T15:29:17.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The site’s revision tag was updated from v3.6.4 to v3.6.5, reflecting a new release version of the software or page framework.
    Difference
    0.0%
    Check dated 2026-08-08T23:44:28.000Z thumbnail image

Stay in the know with updates to Switching to Cabotegravir and Rilpivirine: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.